New Stocks – Feb 2018

New month – new stocks to add!

Over the last few months, I have been looking at how I can diversify my portfolio and add some strong stocks. Based on the research that I provide for these stocks, you can see why people chose to copy in in their eToro Copy Trader


** If you don’t have an eToro account – you can set one up here! **

** Already have an eToro account? Check out my profile! **

67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Note that this does not apply to US Users and eToro USA LLC does not offer CFDs.


In the next few weeks, I’ll be adding the following stocks – reason for choosing them are below. Check out how they are doing on my eToro portfolio

New Stocks

StockSectorProsGrowth (1yr)
$BXDiversified
Financials
Strong growth potential, pays a dividend and solid track record.14%
$CBK.DEBanksExcellent growth potential, liabilities are made up of primarily low risk sources of funding and pays a dividend42%
$CMEDiversified
Financials
Excellent dividend payer, strong balance sheet, the level of debt compared to net worth has been reduced over the past 5 years (13.2% vs 10.7% today)15%
$DB1.DEDiversified
Financials
Established dividend payer, flawless balance sheet, interest on debt is well covered by earnings12%
$FCA.MIAutomobilesSolid track record and currently undervalued stock price.12%
$GDCapital GoodsPays a dividend, great performance history, good value based on earning compared to the US Market7%
$JD.CHRetailHigh growth potential, Total debt is well covered by annual operating cash flow (64.3%, greater than 20% of total debt).45%
$LLOY.LBanksExcellent balance sheet, pays a dividend and has a proven track record14%
$MTZCapital GoodsExcellent value for money, long tenure of Board of Directors, assets cover its long-term commitments10%
$NTES.CHSoftwareExcellent balance sheet, solid performance history, pays a dividend, NetEase earns more interest than it pays16%
$PBYIPharmaceutical and BiotechHigh growth potential, has no debt, tenure for management team is above average term length55%
$TTWOSoftwareFlawless balance sheet with reasonable growth potential and it’s cash and other short-term assets cover its long term commitments.76%
$UNHHealthcareReasonable growth potential, pays a good dividend and a strong history.13%
0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Maxima Ruscher
4 years ago

I’m so happy to read this. This is the kind of manual that needs to be given and not the random misinformation that is at the other blogs. Appreciate your sharing this best doc.